(Q38058054)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

17 February 2020

main subject

biomarker

0 references

0 references

author

Thomas Krüger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Julian Grosskreutz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Janin Lautenschläger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Heidrun Rhode

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

1 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

Proteomics - Clinical Applications

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

123-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Epidemiological study of amyotrophic lateral sclerosis and allied disorders in the Kii peninsula (Japan)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Electrodiagnostic criteria for diagnosis of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Mutations of optineurin in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Exome sequencing reveals VCP mutations as a cause of familial ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

New pathological findings in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Beta-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Excitotoxic potential of the cyanotoxin β-methyl-amino-L-alanine (BMAA) in primary human neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Molecular biology of amyotrophic lateral sclerosis: insights from genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Golgi apparatus and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Biomarkers in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Biomarker discovery in neurodegenerative diseases: a proteomic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Peptide profiling of cerebrospinal fluid by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Identification of potential CSF biomarkers in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Axonal damage markers in cerebrospinal fluid are increased in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Elevated serum angiogenin levels in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

TDP-43 plasma levels are higher in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Salivary chromogranin A: useful and quantitative biochemical marker of affective state in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Biochemical markers in CSF of ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Amyotrophic lateral sclerosis: new developments in diagnostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Urinary collagen metabolite excretion in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Amyotrophic lateral sclerosis: unusually low content of collagen in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

The application of biomarkers in clinical trials for motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Applying proteomics to the diagnosis and treatment of ALS and related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

VCP mutations in familial and sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200067

21 January 2018

Identifiers

DOI

10.1002/PRCA.201200067

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23129563%20AND%20SRC:MED&resulttype=core&format=json

release_gswfj2eiifhknc5uyjgwlhfjhq

17 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gswfj2eiifhknc5uyjgwlhfjhq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference